Javid Moslehi, MD
Dr. Moslehi is an Associate Professor of Medicine at Vanderbilt School of Medicine. He directs the Cardio-Oncology program, a clinical and research program focused on the cardiovascular health of cancer patients. Dr. Moslehi also directs a research laboratory, with general interests that include mechanisms of cardiovascular toxicities that occur as a result of targeted cancer therapies, adverse effects of tumors on the cardiovascular and metabolic systems, cancers that arise from the heart, and the growing appreciation that common risk factors (including genetic mutations) predispose to both cancer and cardiovascular disease. The Moslehi laboratory uses an integrated approach from molecules, cell-based and animal models, and systems biology towards these goals. As well, the laboratory is well integrated into the Vanderbilt cardio-oncology clinical program, with the hope that discoveries in the laboratory will translate into clinical practice.
While members of the Medical Advisory Board are consulted to provide third party expert medical input into Triple-Gene’s product development efforts and clinical trial activities, they do not dictate or direct, nor are they responsible for, any development or clinical activities ultimately undertaken by Triple-Gene.